IFNG and neoplasm: Various strategies of CRISPR screen for novel immunotherapy (IO) targets discovery have been used, including targeting antigen processing and presentation, IFN-γ pathway, TNF signaling, epigenetic regulators, and PD-L1 regulators in tumor cells, and metabolic regulators in T cells (Table 3).